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S U M M A R Y
We describe an outbreak investigation of Pantoea agglomerans bacteraemia associated
with anticoagulant citrateedextrose 46% (ACD) solution prepared in-house. A healthy man
presented with septic shock during plasmapheresis for granulocyte donation. The solution
used for priming and blood samples were sent for culture. Identification of the isolate to
species level was performed by gyrB sequencing. Typing was performed by pulsed-field gel
electrophoresis (PFGE). In total, eight cases were identified during a three-week period.
P. agglomerans was also cultured from six ACD solution bags. Isolates from patients and
ACD bags were identical by PFGE. All isolates were susceptible to ampicillin, cephazolin,
gentamicin, ciprofloxacin, cefepime and imipenem.
 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
Introduction
Pantoea spp. constitute a genus formerly classified as
Erwinia herbicolaeEnterobacter agglomerans complex.1 Pan-
toea ananatis and Pantoea dispersa are causes of human
infections.2,3 Biochemical heterogeneity of the genus causes
difficulty with identification.
Pantoea spp. have been isolated from environmental niches
and from humans and animals as a commensal.1 P. agglomerans
is the most frequent species associated with human infec-
tions.1 Nosocomial outbreaks due to contamination of total
parenteral nutrition, propofol, blood products and trans-
ference tubes used for intravenous hydration have previously
been described.4e7
This study describes an outbreak of P. agglomerans in
a tertiary care centre related to in-house-produced anticoag-
ulant solution used for priming of the plasmapheresis machine
and for haemodialysis in acute care.
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Methods
Setting
Hospital das Clı´nicas is a tertiary care teaching hospital
affiliated to the University of Sa˜o Paulo, Brazil. It has about
2500 beds divided among six institutes. The hospital has
a haemodialysis unit and a blood bank service that are located
in the central institute and serve the whole hospital.
The central pharmacy produces the anticoagulant solution
ACD (anticoagulant citrateedextrose 46%) and distributes it to
the whole hospital including to the division of haematology and
to the haemodialysis unit. In the haematology department,
ACD is added to plasmin (pentamideehydroxyethylamide) and
it is used to prime the plasmapheresis system before each
procedure. The haemodialysis unit uses ACD in acute care as an
anticoagulant for cases in which heparin is contraindicated.
The outbreak
On 4 January 2010, a previously healthy 44-year-old man
presentedwith rigors, chills and fever (temperature>38 C)while
donating granulocytes at the blood bank. The attending
physician interrupted the procedure and collected a sample of
the ACD/plasmin solution used to prime the plasmapheresis
system. Additional blood samples were obtained from the patient
and all samples were sent for culture. Culture of the ACD/plasmin
solution yielded Pantoea sp.
Control measures
The infection control team implemented the following
measures:
 The infection control teams of the five other institutes
were notified.
 Weekly meetings took place involving infection control,
central pharmacy, microbiology laboratory, haematology
and nephrology and the hospital administration.
 Visits to the pharmacy and the hospital units. Points
evaluated in the pharmacy were packaging, sterilization,
traceability of batches and storage. Evaluation of patient
units included the storage of ACD, handling, infusion and
practices related to infusion therapy.
 The pharmacy traced the whole ACD batch related to the
index case. A recall was implemented. Surveillance of
blood cultures to identify new cases was maintained for
six months.
Investigation
Although the blood culture obtained from the granulocyte
donor was negative, we considered him as the index case.
Case definitions were as follows:
1. Confirmed case: isolation of Pantoea sp. in blood cultures,
on 28 November 2009 (date of production of ACD batch
used on index patient) or later, from patients who had
undergone plasmapheresis or haemodialysis for acute care
at our hospital.
2. Possible case: fever, chills or shivering during or after
dialysis or plasmapheresis with a negative blood culture, on
28 November 2009 or later.
3. Suspected case: septic shock or sepsis in patients under-
going dialysis or plasmapheresis, on 28 November 2009 or
later, in which Enterobacter sp. or Citrobacter sp. were
identified from blood cultures. These micro-organisms
were included based on the possibility of misidentifica-
tion of Pantoea spp. due to potential limitations of our
automated system (Vitek 1, bioMe´rieux Vitek, Hazelwood,
MO, USA) used during the whole second semester of 2009.
Data from cases were collected from patients’ records and
the computer laboratory.
ACD samples from the same batch received by the case
patients were cultured.
Microbiology
The micro-organisms were initially identified using Gram-
negative cards of Vitek 1 (bioMe´rieux, Hazelwood, MO, USA).
Because of doubts with the identification, conventional
biochemical tests were performed. During January 2010, the
microbiology laboratory gradually migrated over a few weeks
from the automated system Vitek 1 to Vitek 2, and the three
initial isolates were identified as Enterobacter intermedius/
Rahnella aquatilis. These were re-identified later as Pantoea
sp. Antimicrobial susceptibility testing was performed using
broth microdilution according to the Clinical and Laboratory
Standards Institute recommendations. Isolates were re-
identified by API20E (bioMe´rieux, Marcy l’Etoile, France) and
species confirmed by gyrB sequencing. Nucleotide sequencing
to confirm the species was performed by MegaBACE 1000 (GE
Healthcare). The sequences were analysed using the software
Sequence Analyzer with the Base Caller Cimarron 3.12. The
genetic sequence was compared with the database BLAST
(http://www.ncbi.nlm.nhi.gov/blast/).
Molecular typing
Pulsed-field gel electrophoresis (PFGE) was performed for
isolates obtained from ACD bags and patients, using CHEF-DRII
(Bio-Rad Laboratories Inc., Berkeley, CA, USA), after digestion
by Xba-I restriction enzyme. The interpretive criteria were
those by Tenover et al.8 Controls used were Enterobacter
cloacae ATCC 13047 and Pseudomonas aeruginosa ATCC 27853.
Endotoxin assay
Bacterial endotoxin assay was performed using the gel
formation method as described elsewhere (Pharmacopeia
Americana).9
Results
From 31 December 2009 through 19 January 2010 there were
six confirmed cases (Figure 1) of Pantoea sp. infection plus the
index case. Later an eighth individual who did not fulfil criteria,
because he had not undergone plasmapheresis or haemodial-
ysis, was included as a case because he presented with a posi-
tive blood culture with the same clone of Pantoea sp. The
patients’ characteristics are presented in Table I.
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No possible cases were identified. One unrelated case of
Pantoea agglomerans bacteraemia was identified in the
neonatology ward.
Although seven patients fulfilled the criteria for suspected
cases they were not confirmed as Pantoea sp.
The pharmacy traced 500 ACD bags belonging to the same
batch as the one used by the index patient: 50 ACD bags in the
central institute (22 were withdrawn and 28 had been already
used) where four cases occurred; and 405 in the heart institute
(292 were withdrawn and 113 had been used) where the four
other cases occurred. In addition, 45 bags were traced to the
children’s institute, with no cases (43 were withdrawn and two
had been used).
Evaluation of the hospital’s compound pharmacy did not
indicate technical problems during production although the
final step, bottling, was totally manual. During visits to the
hospital units it was noticed that ACD bags were stored in the
wards, which was not recommended. We promoted training
sessions about hand hygiene and revision of good practices on
intravenous drug manipulation. We recommended imple-
mentation of traceability of delivered drugs to the patient
level. Finally, we discussed with the hospital’s chief executive
officer the cost-benefit of in-house preparation of intravenous
solution and advocated changes in order to acquire industry-
produced solutions. After the control measures had been
implemented and the implicated ACD batch had been with-
drawn, no new cases occurred during follow-up.
All isolates were susceptible to ampicillin [minimum inhib-
itory concentration (MIC50 and MIC90: 1 mg/mL), cephazolin
(MIC50 and MIC90: 1 mg/mL), gentamicin (MIC50 and MIC90
<0.25 mg/mL), ciprofloxacin (MIC50 and MIC90 <0.25 mg/mL),
cefepime (MIC50 and MIC90 <0.25 mg/mL) and imipenem (MIC50
and MIC90 <0.5 mg/mL).
GyrB sequencing and BLAST analysis demonstrated 100%
correspondence with P. agglomerans ATCC 27990 (formerly
known as Enterobacter sp. ATCC 27990). PFGE demonstrated
that all isolates were identical. No bacterial endotoxin was
detected in ACD samples.
Discussion
This study reports an outbreak of P. agglomerans bacter-
aemia, caused by the contamination of ACD solution produced
by the hospital’s compound pharmacy. The outbreak occurred
in patients receiving haemodialysis and plasmapheresis. Poor
adherence to hand hygiene, low quality of hand hygiene,
environmental contamination (not investigated), may have
contributed to the contamination. Pantoea spp. have been
involved in outbreaks of healthcare-associated infections
(HCAIs) probably due to its ability to grow in glucose-enriched
solutions widely used in hospitals.2e4 Its importance as a cause
of HCAI is probably underestimated because, until recently,
Pantoea belonged to the genus Enterobacter, a much better
known hospital pathogen.
Table I
Demographic data, exposure factors and outcomes of patients with Pantoea agglomerans bloodstream infection during an outbreak caused
by contaminated anticoagulant citrateedextrose (ACD), Hospital das Clı´nicas, December 2009eJanuary 2010
Patient Institute Sex Age
(years)
Diagnosis Dialysis Anticoagulant
used in dialysis
Plasmapheresis ACD
priming
Outcome
Index case Central M 44 Granulocyte
donor
No e Yes Yes Cure
2 Central F 22 TTP No e Yes Yes Cure
3 Central M 68 GBS Yes Heparin Yes Yes Cure
4 Central M 52 TTP No e Yes Yes Death
5 Heart F 83 CCF Yes ACD No NA Death
6 Heart F 55 Lung Tx Yes ACD No NA Death
7 Heart F 72 CCF Yes ACD No NA Death
8 Heart M 67 Lung Tx No NA No NA Death
M, male; F, female; TTP, thrombotic thrombocytopenic purpura; GBS, GuillaineBarre´ syndrome; CCF, cardiac congestive failure; Tx,
transplant; NA, not applicable.
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Figure 1. Distribution of Pantoea agglomerans bacteraemia during the outbreak period. The arrow indicates the day of the index case
(donor of granulocytes) which initiated the investigation.
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In this study difficulties with identification delayed the
recognition of the outbreak and introduction of early preven-
tive measures. The occurrence of an entirely new genus
causing bacteraemia (identified by Vitek 2) brought this to our
attention, but there was the possibility that other cases had
been undetected because they had been identified differently
(identified by Vitek 1) such as Enterobacter sp. and Citrobacter
sp. This led us to create a definition for suspected cases but no
such cases were identified.
Species of the genus Pantoea are closely related pheno-
typically, making rapid species identification difficult. In the
present study gyrB gene sequencing provided the identifica-
tion. With the problems in identification, the outbreak may
have been overlooked and the control measures delayed. In our
study susceptibility was universal to beta-lactams, amino-
glycosides, and quinolones.
Contamination of medication or solutions can occur during
the process of manufacturing or the manipulation of multidose
vials. In our outbreak, the contamination probably occurred
during manufacturing. Drugs and products produced in
compound pharmacies have been reported to be the cause of
outbreaks.10 Industry production of intravenous solutions is
probably safer. In addition, sterility control performed before
the release of the solutions failed to detect contamination. We
hypothesize that a small inoculum contaminated the dextrose-
rich solution which acted as a culture medium for the agent.
Furthermore, the conditions of storage were frequently
inadequate.
In conclusion, strict protocols of good practices should be
assured in order to prevent contamination, when in-house
manipulation of solutions cannot be avoided. This should
include continuous education on good quality hand hygiene and
rigorous observation of environment control in the handling
area. Finally, we advocate that in-house manipulation should
be abandoned and hospitals should only use industry-produced
intravenous solutions. Efforts to trace all drugs used in patients
should be employed if contamination occurs, to identify
problems early and avoid new exposures.
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